Table 1. The functions of EVs derived from BM cells.
| Source cell | Type of EVs | Target cell | Functions | Ref. |
|---|---|---|---|---|
| MSC | EVs | Treg, CD3+cell | Promote proliferation and apoptosis of Treg; induce CD3+ cell apoptosis | 36 |
| MSC | Exosomes | Immune cell | Induce immunosuppression | 37 |
| MSC | Microvesicles | PBMC | Decrease Th17 cells and increase Treg | 35 |
| MSC | Microparticles and exosomes | Proximal tubular epithelial cell | Promote cell proliferation | 33 |
| MSC | EVs | Endothelial cell | Promote tube formation and proliferation | 38 |
| MSC | 40-150nm EVs | Breast cancer cell | Promote tumor growth in vivo | 34 |
| BMSC | Exosomes | Breast cancer cell | Reduce CXCL12 and decreased proliferation | 41 |
| MSC | Exosomes | Gastric cancer cells | Promote tumor growth in vivo | 42 |
| MSC | Microvesicles | Hepatoma, Kaposi's sarcoma, and ovarian tumor cell lines | Inhibit cell cycle progression; induce apoptosis; inhibit tumor growth in vivo | 43 |
| MSC | EVs | Glioblastoma cell line | Decrease cell proliferation, induced apoptosis | 44 |
| peptide-pulsed DC | Exosomes | T cell | Induce specific cytotoxic T lymphocytes in vivo and suppress tumor growth | 48 |
| DC | Exosomes | NK cell | Induce NK cell proliferation and activation in vivo | 49 |
| imDC | Exosomes | NK cell | NK cell activation | 50 |
| DC | Exosomes | CD4+ T cell | T cell activation | 51 |
| DC | Exosomes | iNKT cell | Activate iNKT cells and induce cancer-specific adaptive immune response | 52 |
| DC | Antigen-loaded exosomes | T cell | Induce specific transgenic T cell proliferation and response; Th1-type shift | 53 |
| DC | Antigen-loaded exosomes | CD8+T cell | Induce cytotoxic T cell response | 54 |
| imDC | Exosomes | Lymphocyte | Reduce proliferation | 56 |
| imDC | Exosomes | T cell | Suppress T cell response and increase IL-10 production | 57 |
| imDC | Exosomes | T cell | Immunosuppression | 58 |
| DC | Exosomes | T cell | Reduce T cell responses | 59 |
| imDC | Exosomes | T cell | Stimulate CD4+ T cells | 61 |
| imDC treated with IL-10 | Exosomes | N/A | Suppress inflammation and autoimmune responses | 63 |
| DC over-expressing FasL | Exosomes | N/A | Induce antigen-specific immune responses in vivo | 65 |
| DC over-expressing IL-4 | Exosomes | DC, macrophage, T cell | Suppress inflammatory response | 66 |
| Infected macrophages | 50-300 nm EVs | Naive macrophage | Induce pro-inflammatory cytokines production | 70 |
| Infected macrophages | Exosomes | DC, T cell | Stimulate activation and maturation of DC; activate antigen-specific CD4+ and CD8+ T cells | 71 |
| Infected macrophages | Exosomes | Naive macrophage | Recruit and activate macrophage | 72 |
| Infected macrophage | Exosomes | Naive macrophage | Suppress IFN-γ mediated activation of naive macrophages | 73 |
| Mast cells | Exosomes | Spleen cell | Promote proliferation, IL-2 and IFN-γ production | 74, 75 |
| Adipocytes | Exosomes | Osteoblast | Induce the expression of adipocyte specific genes | 76 |
EV, extracellular vesicle, MSC, mesenchymal stromal cells; Treg, regulatory T cells; BMSC, bone marrow stromal cells; DC, dendritic cells; iNKT cell: invariant natural killer T cell.